Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Autoliv (ALV) downgraded to Sell at Evercore ISI by analyst Arndt Ellinghorst, who expects Autoliv to underperform the industry growth rate in ADAS/AEB through the end of the decade due to their go-alone algorithm strategy, Takata tailwinds flatten out starting in 2016, R&D expense will be elevated over the next 2-3 years, and shares have the highest recession downside in the group. 2. Ecolab (ECL) downgraded to Sell at Goldman with analyst Robert Koort expressing concern about tempered growth from cyclical headwinds in its relatively new energy business and potential multiple compression. 3. Amec Foster Wheeler (AMFW) downgraded to Underperform at Macquarie by analyst David Farrell, who said the recent rally in the shares provides a time to take profits. 4. Monsanto (MON) downgraded to Neutral at Citi by analyst P.J. Juvekar, who said near-term catalysts are limited with the company's high-tech biotech seeds seeing pricing pressure. 5. Team Health (TMH) downgraded to Neutral at JPMorgan by analyst Gary Taylor, who is skeptical of Team Health takeover interest in the near-term and is concerned that the company's 2016 guidance could be too aggressive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.